Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 784

1.

Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing-remitting multiple sclerosis.

Meyer D, Coles A, Oyuela P, Purvis A, Margolin DH.

Mult Scler Relat Disord. 2013 Jan;2(1):60-3. doi: 10.1016/j.msard.2012.07.002. Epub 2012 Sep 25.

PMID:
25877456
2.

Serial Measurements of Serum Thyroglobulin in Response to Recombinant Human Thyrotropin (rhTSH) Stimulation.

Weiss RJ, Magner J.

Thyroid. 2015 Apr 8. [Epub ahead of print] No abstract available.

PMID:
25850337
3.

Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency).

McGovern MM, Wasserstein MP, Kirmse B, Duvall WL, Schiano T, Thurberg BL, Richards S, Cox GF.

Genet Med. 2015 Apr 2. doi: 10.1038/gim.2015.24. [Epub ahead of print]

PMID:
25834946
4.

The human sex ratio from conception to birth.

Orzack SH, Stubblefield JW, Akmaev VR, Colls P, Munné S, Scholl T, Steinsaltz D, Zuckerman JE.

Proc Natl Acad Sci U S A. 2015 Mar 30. pii: 201416546. [Epub ahead of print]

5.

Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial.

Cox TM, Drelichman G, Cravo R, Balwani M, Burrow TA, Martins AM, Lukina E, Rosenbloom B, Ross L, Angell J, Puga AC.

Lancet. 2015 Mar 25. pii: S0140-6736(14)61841-9. doi: 10.1016/S0140-6736(14)61841-9. [Epub ahead of print]

PMID:
25819691
6.

Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation.

Bae EJ, Yang NY, Lee C, Lee HJ, Kim S, Sardi SP, Lee SJ.

Exp Mol Med. 2015 Mar 27;47:e153. doi: 10.1038/emm.2014.128.

7.

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease.

Germain DP, Charrow J, Desnick RJ, Guffon N, Kempf J, Lachmann RH, Lemay R, Linthorst GE, Packman S, Scott CR, Waldek S, Warnock DG, Weinreb NJ, Wilcox WR.

J Med Genet. 2015 May;52(5):353-8. doi: 10.1136/jmedgenet-2014-102797. Epub 2015 Mar 20.

8.

A new use for existing technology - continuous precipitation for purification of recombination proteins.

Warikoo V, Godawat R.

Biotechnol J. 2015 Mar 17. doi: 10.1002/biot.201400840. [Epub ahead of print] No abstract available.

PMID:
25781861
9.

Specificity for a CCR5 inhibitor is conferred by a single amino acid residue: role of Ile198.

Lau G, Labrecque J, Metz M, Vaz R, Fricker SP.

J Biol Chem. 2015 Mar 12. pii: jbc.M115.640169. [Epub ahead of print]

PMID:
25767113
Free Article
10.

Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network De-regulation.

Wagenaar TR, Zabludoff S, Ahn SM, Allerson C, Arlt H, Baffa R, Cao H, Davis S, Garcia-Echeverria C, Gaur R, Huang SM, Jiang L, Kim D, Metz-Weidmann C, Pavlicek A, Pollard J, Reeves J, Rocnik JL, Scheidler S, Shi C, Sun F, Tolstykh T, Weber W, Winter C, Yu E, Yu Q, Zheng G, Wiederschain D.

Mol Cancer Res. 2015 Mar 10. pii: molcanres.0703.2014. [Epub ahead of print]

PMID:
25758165
11.

Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints.

Kakkis ED, O'Donovan M, Cox G, Hayes M, Goodsaid F, Tandon PK, Furlong P, Boynton S, Bozic M, Orfali M, Thornton M.

Orphanet J Rare Dis. 2015 Feb 10;10(1):16.

12.

Disease-related determinants of quality of life 10 years after clinically isolated syndrome.

Kinkel RP, Laforet G, You X.

Int J MS Care. 2015 Jan-Feb;17(1):26-34. doi: 10.7224/1537-2073.2013-041.

13.

Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens.

Bar-Or A, Wiendl H, Miller B, Benamor M, Truffinet P, Church M, Menguy-Vacheron F.

Neurol Neuroimmunol Neuroinflamm. 2015 Feb 12;2(2):e70. doi: 10.1212/NXI.0000000000000070. eCollection 2015 Apr.

14.

Sclerostin and CKD-MBD.

Schiavi SC.

Curr Osteoporos Rep. 2015 Feb 19. [Epub ahead of print]

PMID:
25691219
15.

Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial.

Mistry PK, Lukina E, Ben Turkia H, Amato D, Baris H, Dasouki M, Ghosn M, Mehta A, Packman S, Pastores G, Petakov M, Assouline S, Balwani M, Danda S, Hadjiev E, Ortega A, Shankar S, Solano MH, Ross L, Angell J, Peterschmitt MJ.

JAMA. 2015 Feb 17;313(7):695-706. doi: 10.1001/jama.2015.459.

PMID:
25688781
16.

Novel GAA mutations in patients with Pompe disease.

Turaça LT, de Faria DO, Kyosen SO, Teixeira VD, Motta FL, Pessoa JG, Rodrigues E Silva M, de Almeida SS, D'Almeida V, Munoz Rojas MV, Martins AM, Pesquero JB.

Gene. 2015 Apr 25;561(1):124-31. doi: 10.1016/j.gene.2015.02.023. Epub 2015 Feb 12.

PMID:
25681614
17.

Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: a pilot study.

Pang J, Sullivan DR, Harada-Shiba M, Ding PY, Selvey S, Ali S, Watts GF.

J Clin Lipidol. 2015 Jan-Feb;9(1):42-8. doi: 10.1016/j.jacl.2014.09.011. Epub 2014 Sep 28.

PMID:
25670359
18.

Recommendations for the evaluation of specimen stability for flow cytometric testing during drug development.

Brown L, Green CL, Jones N, Stewart JJ, Fraser S, Howell K, Xu Y, Hill CG, Wiwi CA, White WI, O'Brien PJ, Litwin V.

J Immunol Methods. 2015 Mar;418:1-8. doi: 10.1016/j.jim.2015.01.008. Epub 2015 Feb 4. Review.

PMID:
25662815
19.

Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.

Case LE, Bjartmar C, Morgan C, Casey R, Charrow J, Clancy JP, Dasouki M, DeArmey S, Nedd K, Nevins M, Peters H, Phillips D, Spigelman Z, Tifft C, Kishnani PS.

Neuromuscul Disord. 2015 Apr;25(4):321-32. doi: 10.1016/j.nmd.2014.12.004. Epub 2014 Dec 19.

20.

Dimorphic Effects of Transforming Growth Factor-β Signaling During Aortic Aneurysm Progression in Mice Suggest a Combinatorial Therapy for Marfan Syndrome.

Cook JR, Clayton NP, Carta L, Galatioto J, Chiu E, Smaldone S, Nelson CA, Cheng SH, Wentworth BM, Ramirez F.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):911-7. doi: 10.1161/ATVBAHA.114.305150. Epub 2015 Jan 22.

PMID:
25614286
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk